Zoetis Stock

Zoetis Dividend

The Dividend of Zoetis (ZTS) as of Aug 12, 2026 is 2.00 USD. In the previous year, Dividend was 1.73 USD — a change of 15.74% (higher).

Dividend

2.00USD

YoY

15.74%

Dividend yield

2.65 %

Last updated:

How much dividend does Zoetis 2026 pay?

According to the latest status from August 2026, Zoetis paid a total of 2.00 USD per share in dividends within the last 12 months. With the current Zoetis price of 75.35 USD, this corresponds to a dividend yield of 2.76 %. A dividend is paid times per year.

Zoetis currently offers a dividend yield of about 2.65%. The payout ratio is around 33% of earnings. The dividend has grown at 21.4% per year over the past 12 years.

Historical Zoetis Dividends

A dividend is paid times per year. Last year, the payout months were February, May, August and December.

PaydateDividend
5/20/20260.53USD
2/20/20260.53USD
12/1/20250.50USD
8/18/20250.50USD
5/21/20250.50USD
2/21/20250.50USD
12/1/20240.43USD
8/18/20240.43USD
5/18/20240.43USD
2/18/20240.43USD
12/1/20230.38USD
8/20/20230.38USD
5/20/20230.38USD
2/19/20230.38USD
12/1/20220.33USD
8/20/20220.33USD
5/20/20220.33USD
2/19/20220.33USD
11/28/20210.25USD
8/20/20210.25USD

Zoetis dividend history and estimates

In 2025, Zoetis paid a dividend amounting to 2.00 USD. Dividend means that Zoetis distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
1.00 USD
0.00 USD
Jan 1, 2022
1.30 USD
0.00 USD
Jan 1, 2023
1.50 USD
0.00 USD
Jan 1, 2024
1.73 USD
0.00 USD
Jan 1, 2025
2.00 USD
0.00 USD
Jan 1, 2026 (e)
0.53 USD
1.59 USD
Jan 1, 2027 (e)
0.00 USD
2.52 USD
Jan 1, 2028 (e)
0.00 USD
3.00 USD

Is the Zoetis Dividend Safe?

Zoetis has been increasing the dividend for 12 years.

Over the past 10 years, Zoetis has increased it by an annual 19.67%.

Over a five-year period, the distribution rose by 20.11%.

Analysts expect a Dividend Increase of 2.96% for the current fiscal year.

Zoetis dividend payout ratio

In 2025, Zoetis had a payout ratio of 32.82%. The payout ratio indicates the percentage of the company's profits that Zoetis distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
23.35 %
Jan 1, 2022
28.71 %
Jan 1, 2023
29.44 %
Jan 1, 2024
31.36 %
Jan 1, 2025
32.82 %
Jan 1, 2026 (e)
30.82 %
Jan 1, 2027 (e)
34.25 %
Jan 1, 2028 (e)
37.67 %

Dividend Details

Understanding Zoetis's Dividend Distributions

Zoetis’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Zoetis's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Zoetis's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Zoetis’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Zoetis Stock analysis

What does Zoetis do? Zoetis Inc. is a leading company in the development and marketing of animal health technology and solutions. The company specializes in innovative products for animals such as dairy cattle, pigs, poultry, dogs, cats, and horses. Zoetis was founded in 1952 as a subsidiary of Pfizer and operated as Pfizer Animal Health. In 2013, the company was finally spun off from Pfizer and became Zoetis Inc. Zoetis focuses on the development, manufacturing, and marketing of products for livestock and pets, including vaccines, pharmaceuticals, biological therapies, and diagnostics. The company operates globally and has its headquarters in Parsippany, New Jersey. Zoetis' business model consists of various business segments divided into animal categories: cattle, pigs, poultry, pets, and horses. Each of these business segments offers specialized solutions for animal owners and veterinarians. In the cattle products segment, Zoetis offers products for dairy cows, beef cattle, and calves. They also provide a variety of prevention and treatment solutions for major animal health issues such as mastitis, reproductive disorders, and respiratory problems. In the swine segment, Zoetis offers prevention and treatment solutions for infectious diseases and parasite control. They also provide products for promoting swine health and weight gain. In the poultry segment, Zoetis offers solutions for the prevention and treatment of infectious diseases. The company's products aim to improve animal health, productivity, and efficiency. Zoetis also offers products for the pet segment, including vaccines, pharmaceuticals, and therapies for dogs, cats, and other pets. Here, the company also provides solutions for major health issues such as heart diseases, pain management, and parasite control. In the horse segment, Zoetis offers solutions for the prevention and treatment of diseases such as equine rhinopneumonia, worm infestations, and arthritis. They also provide products for promoting horse health and performance. Zoetis is known for a variety of innovative products used by animal owners and veterinarians worldwide. One example is ScourGuard® 4KC, a vaccine that protects calves from diarrheal diseases caused by common bacteria. This vaccine has already proven to be highly effective in controlling bowel diseases in calves. Zoetis has also developed and marketed the first FDA-approved product for pain management in dogs (Rimadyl®), as well as the first licensed product for the treatment of giardia in dogs (Panacur®). In summary, Zoetis, as a global leader in the animal health industry, puts innovation and quality at the forefront. With a wide range of products and solutions in various animal categories, Zoetis is a key player in the animal health industry. Zoetis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zoetis stock

Over the past 12 months, Zoetis paid a dividend of 2.00 USD . This corresponds to a dividend yield of about 2.65 %. For the coming 12 months, Zoetis is expected to pay a dividend of 2.52 USD.

The current dividend yield of Zoetis is 2.65 %.

Zoetis pays a dividend, distributed in the months of , , , .

Zoetis paid dividends every year for the past 13 years.

For the upcoming 12 months, dividends amounting to 2.52 USD are expected. This corresponds to a dividend yield of 3.44 %.

Zoetis is assigned to the 'Health' sector.

To receive the latest dividend of Zoetis from amounting to 0.53 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Zoetis distributed 1.8 USD as dividends.

The dividends of Zoetis are distributed in USD.

Dividend calendar 2026
Access this data via the Eulerpool API

All Key Metrics — Zoetis